BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -302.64% | -448.07% | 44.82% | -157.29% | -110.33% |
| Total Depreciation and Amortization | -2.50% | 237.28% | -126.07% | 170.93% | -4.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -314.58% | -51.01% | -- | -- | -815.59% |
| Change in Net Operating Assets | 882.69% | 113.79% | -1,353.89% | -102.30% | 642.63% |
| Cash from Operations | -81.58% | 156.77% | -302.54% | -83.02% | 2,155.08% |
| Capital Expenditure | -- | 100.00% | -- | -- | -77.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.59% | 95.44% | -- | -- | -- |
| Cash from Investing | -29.85% | 95.67% | -- | -- | -77.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.28% | 110.78% | -918.97% | -82.95% | 2,264.06% |